Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV002246781 | SCV002519886 | benign | not specified | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002246781 | SCV003859459 | uncertain significance | not specified | 2023-01-20 | criteria provided, single submitter | clinical testing | The p.N619I variant (also known as c.1856A>T), located in coding exon 14 of the RECQL gene, results from an A to T substitution at nucleotide position 1856. The asparagine at codon 619 is replaced by isoleucine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |